being which influence overall activity patterns. Furthermore, no attempts have been made to relate changes in total or resting energy expenditure to those in body composition in children treated with hGH. Accurate measurement of total energy expenditure in children was previously impossible in the free living state until the advent of the non-invasive doubly labelled water (2H2'80) method using stable, nonradioactive isotopes.'01' We hypothesised that the early metabolic effects of hGH treatment would result in increased energy expenditure, which may be predictive of the subsequent anthropometric effect of treatment. We have therefore measured, before and after six weeks hGH treatment, changes in body composition using H2`'O dilution and compared the results with values obtained from two techniques more easily applicable routinely in the clinic, namely measurement of bioelectrical impedance and skinfold thickness. We have measured resting energy expenditure using indirect ventilated hood calorimetry and free living total energy expenditure using the 2H2'8O method to determine the effects of hGH treatment on energy expenditure and to see if such changes are related to changes in body composition. The results presented here are initial measurements from an ongoing study to assess the long term metabolic and energy expenditure effects of hGH and to discover whether early changes may be predictive of any long term growth promoting effects.
Although growth hormone has been available for the treatment of children with short stature for approximately 30 years,' information on the association of the early metabolic effects of treatment to possible subsequent changes in body composition is limited. Metabolic studies (mostly made in the first one to two weeks of treatment) have shown that human growth hormone (hGH) is anabolic, indicated by nitrogen retention increasing within 24 hours2' and reaching a maximum less than 14 days after initiation of treatment. 7 Also the triceps skinfold thickness, which is a measure of fat mass, decreases six to 10 weeks after the start of treatment. However, studies of other indices of body composition have been made only after longer periods of treatment (for example, total body potassium estimated by 40K counting after seven months), 8 and little attempt has been made to compare the extent of the possible effects, early and late.
There is very little information, none recent, on the energy expenditure changes associated with treatment and the available information is inconsistent.3 ' Most measurements of this sort were of resting energy expenditure and we are unaware of any attempts to measure free living daily total energy expenditure. Total energy expenditure may be affected by changes in well being which influence overall activity patterns. Furthermore, no attempts have been made to relate changes in total or resting energy expenditure to those in body composition in children treated with hGH. Accurate measurement of total energy expenditure in children was previously impossible in the free living state until the advent of the non-invasive doubly labelled water (2H2'80) method using stable, nonradioactive isotopes.'01' We hypothesised that the early metabolic effects of hGH treatment would result in increased energy expenditure, which may be predictive of the subsequent anthropometric effect of treatment. We have therefore measured, before and after six weeks hGH treatment, changes in body composition using H2`'O dilution and compared the results with values obtained from two techniques more easily applicable routinely in the clinic, namely measurement of bioelectrical impedance and skinfold thickness. We have measured resting energy expenditure using indirect ventilated hood calorimetry and free living total energy expenditure using the 2H2'8O method to determine the effects of hGH treatment on energy expenditure and to see if such changes are related to changes in body composition. The results presented here are initial measurements from an ongoing study to assess the long term metabolic and energy expenditure effects of hGH and to discover whether early changes may be predictive of any long term growth promoting effects. and r=0-62, p<005 respectively). Pretreatment resting and total energy expenditure were correlated (r=0-54, p=005). After six weeks of treatment with hGH there was an inverse correlation between absolute changes in fat mass and resting energy expenditure (r= -0-53, p=005). Absolute increases in resting and total energy expenditure over the six week period were positively correlated (r=0-78, p<001). However, none of these observed changes in energy expenditure was correlated with the differing doses of hGH (expressed either as U/kg/week or U/m2/week) received by these patients.
Patients and methods

Discussion
After six weeks of hGH treatment we observed significant increases in fat free mass that have not, so far as we know, been previously detected in children after such a short period of treatment. Unlike the results obtained by previous work in adults,30 however, we have also observed a significant increase in weight, well above that anticipated over a six week period in a growing child. The study in adults has shown an early increase in fluid retention in response to hGH that might be the explanation for the observed significant increase in total body water and derived values of fat free mass measured in our study. A similar increase in fat free mass was detected by decreasing skinfold measurements, however, which might be considered an unlikely response to substantial production of oedema fluid. Therefore the increment in fat free mass indicated both by isotope dilution and impedance was probably genuine and not affected by oedema. Despite significant decreases in skinfold thicknesses, the mean decrease in fat mass was not significant and as net changes in weight were positive, it appears that the most sensitive measure of changes in body composition resulting from hGH treatment is that of an increase in fat free mass. This change in fat free mass can be easily monitored in the clinical situation by either skinfold thickness measurements taken by a single observer, or, if this is clinically inconvenient and different observers have to be involved, by the technique of bioelectrical impedence, which has a lower interobserver coefficient of variation. '8 Unlike those of previous studies in children,3 9 our results show a significant increase in both whole body resting energy expenditure and resting energy expenditure/kg fat free mass and also in whole body total energy expenditure. The percentage change is diminished when expressed as kJ/kg fat free mass reflecting the concurrent increase in absolute fat free mass. This increase in resting energy expenditure may be related to an increase in metabolic activity of lean tissue due to increased protein turnover. However, the increase in resting energy expenditure is significantly associated only with changes in fat mass and not fat free mass, perhaps suggesting that the stored fat is the energy source for subsequent metabolic activity of fat free mass. The increase in resting energy expenditure is not as great as that seen in a recently published study on adults,30 probably reflecting the fact that some of our subjects were not as severely deficient in growth hormone and that measurements in the adult study were made after only four weeks of treatment. If the greatest metabolic effect of treatment (for example, nitrogen retention) occurs within two weeks of starting treatment and decreases thereafter, the measurable energy cost of such changes may be decreasing between four and six weeks.
If it is assumed that fat free mass contains 
